Smartleaf Asset Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7K Buy
2,323
+740
+47% +$6.16K ﹤0.01% 1907
2025
Q4
$11.9K Buy
1,583
+1,238
+359% +$8.48K ﹤0.01% 2315
2025
Q3
$2.28K Buy
345
+216
+167% +$1.46K ﹤0.01% 2584
2025
Q2
$892 Buy
129
+56
+77% +$380 ﹤0.01% 2495
2025
Q1
$530 Sell
73
-351
-83% -$2.76K ﹤0.01% 2688
2024
Q4
$3.39K Buy
424
+186
+78% +$1.61K ﹤0.01% 2377
2024
Q3
$1.74K Buy
+238
New +$1.7K ﹤0.01% 2520

Other funds holding VMD

Smartleaf Asset Management's VMD Position: Q1 2026 in Review

Smartleaf Asset Management increased its Viemed Healthcare (VMD) stake by 47% in Q1 2026, buying an estimated $6.16K and bringing the position to 2,323 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Smartleaf Asset Management first reported a position in VMD in Q3 2024 and has held it in 7 quarters since. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Smartleaf Asset Management held 2,323 shares of Viemed Healthcare worth $21.7K as of Q1 2026.
  • Smartleaf Asset Management bought 740 Viemed Healthcare shares in Q1 2026, an estimated $6.16K.
  • Viemed Healthcare made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1907 holding.
  • Smartleaf Asset Management first reported a position in Viemed Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.